Literature DB >> 31102363

[Mechanisms of herpes simplex virus latency and reactivation].

Boqiang Sun1, Qiongyan Wang1, Dongli Pan1.   

Abstract

Herpes simplex virus (HSV), including HSV-1 and HSV-2, is an important pathogen that can cause many diseases. Usually these diseases are recurrent and incurable. After lytic infection on the surface of peripheral mucosa, HSV can enter sensory neurons and establish latent infection during which viral replication ceases. Moreover, latent virus can re-enter the replication cycle by reactivation and return to peripheral tissues to start recurrent infection. This ability to escape host immune surveillance during latent infection and to spread during reactivation is a viral survival strategy and the fundamental reason why no drug can completely eradicate the virus at present. Although there are many studies on latency and reactivation of HSV, and much progress has been made, many specific mechanisms of the process remain obscure or even controversial due to the complexity of this process and the limitations of research models. This paper reviews the major results of research on HSV latency and reactivation, and discusses future research directions in this field.

Entities:  

Mesh:

Year:  2019        PMID: 31102363      PMCID: PMC8800643          DOI: 10.3785/j.issn.1008-9292.2019.02.14

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  131 in total

1.  Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0.

Authors:  Michael W Ferenczy; Neal A DeLuca
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

2.  The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription.

Authors:  Nicole J Kubat; Antonio L Amelio; Nicole V Giordani; David C Bloom
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection.

Authors:  Qing-Yin Wang; Changhong Zhou; Karen E Johnson; Robert C Colgrove; Donald M Coen; David M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

4.  Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia.

Authors:  Kamal M Khanna; Robert H Bonneau; Paul R Kinchington; Robert L Hendricks
Journal:  Immunity       Date:  2003-05       Impact factor: 31.745

5.  In vivo changes in the patterns of chromatin structure associated with the latent herpes simplex virus type 1 genome in mouse trigeminal ganglia can be detected at early times after butyrate treatment.

Authors:  Donna M Neumann; Partha S Bhattacharjee; Nicole V Giordani; David C Bloom; James M Hill
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

Review 6.  Herpes Simplex Virus Infections of the Central Nervous System.

Authors:  Richard J Whitley
Journal:  Continuum (Minneap Minn)       Date:  2015-12

7.  Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection.

Authors:  Igor Jurak; Michael Hackenberg; Ju Youn Kim; Jean M Pesola; Roger D Everett; Chris M Preston; Angus C Wilson; Donald M Coen
Journal:  J Virol       Date:  2013-12-04       Impact factor: 5.103

8.  Herpesviral ICP0 Protein Promotes Two Waves of Heterochromatin Removal on an Early Viral Promoter during Lytic Infection.

Authors:  Jennifer S Lee; Priya Raja; David M Knipe
Journal:  MBio       Date:  2016-01-12       Impact factor: 7.867

9.  Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency.

Authors:  Yu Liang; Jodi L Vogel; Aarthi Narayanan; Hua Peng; Thomas M Kristie
Journal:  Nat Med       Date:  2009-10-25       Impact factor: 53.440

10.  Lytic gene expression is frequent in HSV-1 latent infection and correlates with the engagement of a cell-intrinsic transcriptional response.

Authors:  Joel Z Ma; Tiffany A Russell; Tim Spelman; Francis R Carbone; David C Tscharke
Journal:  PLoS Pathog       Date:  2014-07-24       Impact factor: 6.823

View more
  1 in total

1.  BX795 demonstrates potent antiviral benefits against herpes simplex Virus-1 infection of human cell lines.

Authors:  Aqsa Iqbal; Rahul Suryawanshi; Tejabhiram Yadavalli; Ipsita Volety; Deepak Shukla
Journal:  Antiviral Res       Date:  2020-05-05       Impact factor: 5.970

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.